Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03958045
Title Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aman Chauhan

lung small cell carcinoma


Nivolumab + Rucaparib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.